DAA15 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
Molecular |
brain |
Human |
ATP2A2 |
9.0% Decrease Gene Expression Level |
|
DAA16 |
ATPase, Ca++ transporting, plasma membrane 2 |
Molecular |
brain |
Human |
ATP2B2 |
23.0% Decrease Gene Expression Level |
|
DAA21 |
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
Molecular |
brain |
Human |
ATP6V1G2 |
7.0% Decrease Gene Expression Level |
|
DAA19 |
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 |
Molecular |
brain |
Human |
ATP6V0D1 |
8.0% Decrease Gene Expression Level |
|
DAA20 |
ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A |
Molecular |
brain |
Human |
ATP6V1A |
7.0% Decrease Gene Expression Level |
|
DAA1089 |
ATP/GTP Binding Protein-like 5 |
Molecular |
cerebellum |
Human |
AGBL5 |
Increase DNA Methylation |
|
DAA1090 |
ATP/GTP Binding Protein-like 5 |
Molecular |
frontal lobe |
Human |
AGBL5 |
Increase DNA Methylation |
|
DAA1092 |
ATP/GTP Binding Protein-like 5 |
Molecular |
temporal lobe |
Human |
AGBL5 |
Increase DNA Methylation |
|
DAA1091 |
ATP/GTP Binding Protein-like 5 |
Molecular |
pons |
Human |
AGBL5 |
Increase DNA Methylation |
|
DAA17 |
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
Molecular |
brain |
Human |
ATP5A1 |
17.0% Decrease Gene Expression Level |
|
DAA18 |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
Molecular |
brain |
Human |
ATP5B |
9.0% Decrease Gene Expression Level |
|
DAA727 |
Axon loss |
Physiological |
white matter |
Human |
— |
— |
|
DAA24 |
B-cell CLL/lymphoma 11A (zinc finger protein) |
Molecular |
brain |
Human |
BCL11A |
14.0% Decrease Gene Expression Level |
|
DAA23 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
Molecular |
brain |
Human |
B3GALNT1 |
22.0% Decrease Gene Expression Level |
|
DAA1996 |
Beta-amyloid protein deposition increases |
Physiological |
brain |
Human |
APP |
— |
|
DAA25 |
bone morphogenetic protein 7 |
Molecular |
brain |
Human |
BMP7 |
20.0% Increase Gene Expression Level |
|
DAA728 |
Brain matter volume declines |
Physiological |
brain |
Human |
— |
— |
|
DAA1217 |
Brain volume decrease |
Physiological |
brain |
Human |
— |
— |
|
DAA1993 |
Brain volume decreases in a regional-specific way |
Physiological |
brain |
Human |
— |
— |
|
DAA33 |
calbindin 1, 28kDa |
Molecular |
brain |
Human |
CALB1 |
58.0% Decrease Gene Expression Level |
|
DAA765 |
Calcium binding capacity decreases in neurons |
Physiological |
brain |
Human |
— |
— |
|
DAA36 |
calcium/calmodulin-dependent protein kinase IV |
Molecular |
brain |
Human |
CAMK4 |
17.0% Decrease Gene Expression Level |
|
DAA37 |
calcium/calmodulin-dependent protein kinase kinase 2, beta |
Molecular |
brain |
Human |
CAMKK2 |
7.0% Decrease Gene Expression Level |
|
DAA32 |
calcium channel, voltage-dependent, beta 2 subunit |
Molecular |
brain |
Human |
CACNB2 |
8.0% Decrease Gene Expression Level |
|
DAA34 |
calmodulin 1 (phosphorylase kinase, delta) |
Molecular |
brain |
Human |
CALM1 |
5.0% Decrease Gene Expression Level |
|